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applicationsAbstract A simple and sensitive spectrophotometric method has been proposed for the determina-
tion of ﬂutamide (FLD). The method is based on its complexation and oxidation of FLD by Fe3+
and 1,10-phenanthroline. Two sets of condition were established. In the ﬁrst set only FLD reacted
with Fe3+ ion, while in the second one FLD was oxidized by Fe3+ in the presence of 1,10-phenan-
throline. The complexation and oxidation methods were monitored spectrophotometrically. All
variables affecting the development of the color were investigated and the conditions obeying Beer’s
law were optimized. Plots of absorbance against concentration in both methods were rectilinear
over the ranges 0.5–10 and 0.5–1.5 lg mL1, with mean recoveries of 99.51 and 99.83 for methods
A and B respectively. The limits of detection for procedures 1 and 2 are 0.332 and 0.726 lg mL1 1,
respectively. Both the methods were successfully applied for the determination of the FLD in its
dosage form.
ª 2014 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Flutamide (FLD), chemically known as 2-methyl-N-[4-nitro-3-
(triﬂuoromethyl)phenyl]-propanamide (Fig. 1) is widely used
as a antineoplastic (hormonal) and antiandrogen drug
(Budavari et al., 1989; Brogden and Chrisp, 1991; McLeod,
1993; APFH, 2004). It is a powerful nonsteroidal androgen
antagonist, commonly used to treat prostate cancer, is believed
to block androgen receptor sites. Flutamide and its primary
hydroxyl metabolites decrease metabolism of C-19 steroids
by the cytochrome P-450 system at the target cells in theications.
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Fig. 2 Absorbtion spectra of ﬂutamide.
Fig. 1 Chemical structure of FLD.
2 A.A.P. Khan et al.secondary sex organ (Osol and Hoover, 1996). It has been
recently included in the European Pharmacopoeia which
involves a liquid chromatographic method for the determina-
tion of the drug (EP, 2005).
Several methods have been reported for the assay and the
determination of FLD in pure form, in biological and pharma-
ceutical preparation methods, including spectrophotometric
(Nagaraja et al., 2002; Reddy et al., 2003; Rangappa et al.,
2000; Hemavathi et al., 2012), spectroﬂuorometric (Smith
et al., 2008), Voltammetric (Reddy et al., 2011; Hammam
et al., 2004) and HPLC (Filip et al., 2007; Niopas and
Daftsios, 2001; Smith et al., 2009; Salgado et al., 2005).
The spectrophotometric method includes the formation of
yellow color with hydrochloric acid with kmax of 380 nm which
suffers from various drawbacks Zarapkar et al., 1996). The
recently reported three spectrophotometric methods for the
determination of FLD using promethazine hydrochloride or
resorcinol or (NEDA) N-(1-naphthyl) ethylenediamine dihy-
drochloride (Rangappa et al., 2000) have been reported. Two
newly spectrophotometric methods published make use of p-
dimethylamino cinnamaldehyde, NEDA, chromotropic acid
and resorcinol (Reddy et al., 2001).
We have recently reported a detailed study of the interac-
tions of copper(II) with ﬂutamide in the presence of anionic
surfactants by resonance rayleigh scattering, second-order
scattering and frequency doubling scattering (Mohd et al.,
2011).
Although highly expensive, sophisticated and time consum-
ing techniques are available, we are reporting in this paper, a
simple, precise and accurate spectrophotometric method for
rapid determination of FLD. The method is based on the
complexation and oxidation of the drug by Fe3+ ion in the
presence and absence of phenanthroline. Under both the con-
ditions the reactions were monitored spectrophotometrically
by measuring the increase in absorbance at 510 nm.
2. Experimental
2.1. Apparatus
The absorption spectra were obtained with UVD-2960 Double
beam PC connected UV–vis spectrophotometer EL20 Educa-
tion Line pH Meter from Mettler-Toledo Inc.
2.2. Reagents
Distilled water and analytical-reagent grade chemicals were
used. Standard solution of FLD (Sigma Aldrich) was prepared
by dissolving 0.0276 g of the drug in (40:60) ethanol–water
mixture. Working solution containing 25 ml was prepared
from the stock solution. Phenanthroline and ferric chloride
FeCl3.6H2O (Merck) solution were prepared in distilled waterPlease cite this article in press as: Khan, A.A.P. et al., Complexation and oxidation
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and calibrated with pH meter.
2.3. Method A
An aliquot solution containing 0.5–10 lg mL1 of FLD was
transferred to a 10 ml volumetric ﬂask containing 1 ml of
2.50 mol L1 Fe3+ solution and 1 ml acetate buffer of pH
3.5. This mixture made up to the mark with distilled water.
Its absorbance was measured at 510 nm against a reagent
blank.
2.4. Method B
An aliquot solution containing 0.5–1.5 lg mL1 of FLD was
transferred to a 10 ml volumetric ﬂask containing 1.5 ml of
1.2 · 102 mol L1 1,10-phenanthroline and 1 ml acetate buf-
fer of pH5. The solution was warmed on a water bath at
50 C for 10 min followed by the addition of 1.0 mL of
6.5 · 1093 mol L1 Fe3+ solution made up with distilled
water. The increase in absorbance was measured after 25 min
at 510 nm against a blank.
3. Results and discussion
The methanolic solutions of FLD and FLD–Fe3+ complex
were found to absorbance at maximum wavelength at 210,
230, 270 and 510 nm, respectively (Figs. 2 and 3). FLD–
Fe3+ was allowed to react with 1.10-phenanthroline resulting
in the formation of red colored product and obtain the maxi-
mum absorbance at 510 nm (Fig. 3).
The FLD reacted with Fe3+ at pH 3.5 at room tempera-
ture, forming a colored complex according to the equation
given below. However, in acetate buffer of pH 5 at 50 C,
Fe3+ is reduced by FLD in Eq. (2) and subsequently forms
a colored complex with 1,10-phenanthroline which is called
ferroin in Eq. (3) (Marczenko, 1986). The mechanism of ferr-
oin is shown in Scheme 1.
FLDþ Fe3þð1Þ ! Colored Complex ð1Þ
FLDþ Fe3þð2Þ ! Oxidized Products ð2Þ
Fe2þ þ 3Phen! FeðPhenÞ2þ3 ðFerroinÞ ð3Þ
The effect of reaction condition was studied for FLD and its
optimum values for procedures were selected. Two sets of con-
ditions must be fulﬁlled. Under Method A only FLD reactedof Flutamide with Fe3+ and 1,10-phenanthroline: Few analytical applications.
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Fig. 3 Absorption spectra of (A) mixture condition for
FLD= 0.8 lg mL1, Fe3+ = 2.2 · 103 mol L1,pH = 3.5 at
T= 25 C (B) FLD= 1.0 lg mL1, 1,10-phenanthro-
line = 1.30 · 103 mol L1, Fe3+ = 2.2 · 103 mol L1 and
pH = 5.0 at 50 C.
FLD + Fe3+ (1) Colored Complex   (1)
FLD + Fe3+ (2) Oxidized Products   (2)
Fe2+ + 3Phen Fe(Phen)32+ (Ferroin) (3)
Scheme 1 A detailed mechanistic scheme for the complexation
and oxidation of FLD with Fe3+ and 1,10-phenanthroline.
Complexation and oxidation of Flutamide 3while in method B the FLD was oxidized by Fe3+ ion in the
presence of 1,10-phenanthroline.
4. Effect of pH
The effect of pH on the reaction of FLD with Fe3+ was stud-
ied in the range of 2–7. In the ﬁrst procedure only FLD forms
complex with Fe3+. The absorbance of FLD with pH increases
and attains a maximum at pH 3.5. Since at higher pH absorp-
tion decreases an optimum pH of 3.5 was chosen for the ﬁrst
set. Fig. 4 shows the effect of pH on the oxidation of FLD
by Fe3+ in the presence of 1,10-phenanthroline under the sec-
ond set of conditions. Since in this case the absorbance attains
a maximum at pH 5 the subsequent experiments were done at
this pH.0
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Fig. 4 Effect of pH on the complex formation reaction and
oxidation of FLD (A) FLD= 0.8 lg mL1, Fe3+ = 2.2 · 103 -
mol L1, at 25 C (B) FLD= 1.0 lg mL1, 1,10-phenanthro-
line = 1.30 · 103 mol L1 and Fe3+ = 2.2 · 103 mol L1 at
50 C.
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The effect of Fe3+ concentration on the complex formation in
Fig. 5 of FLD was studied in the range of 6.0 · 105 to
5.8 · 103 mol L1. The absorbance of FLD increased with
increasing Fe3+ concentration up to 2.2 · 103 mol L1 and
remained constant at higher concentration. A concentration
of 2.2 · 103 mol L1 Fe3+ ion was therefore chosen for the
ﬁrst set of conditions. Fig. 3 also shows the effect of concentra-
tion of Fe3+ on the oxidation of FLD under the second set of
condition in the range of 6.4 · 105 to 5.8 · 103 mol L1. The
absorbance of FLD increases with increasing Fe3+ concentra-
tion and attains a maximum at 3.8 · 104 mol L1. The con-
centration 3.8 · 104 mol L1 of Fe3+ was therefore, selected
for the second set of conditions.
6. Effect of the concentration of 1,10-phenanthroline
The effect of 1,10-phenanthroline concentration on the absor-
bance of the solution under the second set of condition was
studied in the range of 6.0 · 105–2.40 · 103 mol L1 shown
in Fig. 6. The absorbance of the solution increases with
increasing 1,10-phenanthroline concentration with a maximum
at 1.30 · 103 mol L1. It was therefore, selected as optimum
concentration.
7. Effect of temperature
In order to examine the effect of temperature, the reaction of
FLD with Fe3+ was studied between 25 and 50 C. The vari-
ation in temperature had no effect on the absorbance and
hence experiment was done at 25 C for the ﬁrst set. Since in
the second set of conditions the absorbance increases rapidly
up to 50 C and becomes slow at higher temperature, a temper-
ature of 50 C was chosen for the reaction.
7.1. Kinetic studies
It is clear from the plots in Figs. 7 and 8 that the rate is pro-
portional to the concentration of FLD and obeys the equation:
Rate ¼ K0½FLDn ð4Þ0
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Fig. 5 Effect of Fe3+ ion concentration on the complex
formation and oxidation of FLD (A) FLD= 0.8 lg mL–1,
pH = 3.5 M, at 25 C (B) FLD= 1.0 lg mL–1, 1,10-phenanthro-
line = 1.30 · 103 mol L1 and pH = 5.0 at 50 C.
of Flutamide with Fe3+ and 1,10-phenanthroline: Few analytical applications.
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Fig. 6 Effect of 1,10-phenanthroline concentration on the
absorbance of the ferroin produced from the oxidation of (A)
FLD (B) FLD Fe3+ ion. Condition FLD= 1.0 lg mL–1,
Fe3+ = 2.2 · 103 mol L1 and pH = 5.0 at 50 C.
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Fig. 7 Absorbance vs. time graphs for the reaction of FLD
Oxidation with Fe3+ ion in the presence of 1,10-phenanthroline by
method B.
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Fig. 8 Absorbance vs. time graphs for the reaction of FLD with
Fe3+ ion by the method A.
Table 1 Logarithms of the rates for different concentrations
of FLD applying methods A and B.
Log DA/Dt Log [FLD], (mol L–1)
Reaction with Fe3+ (Method A)
3.942 4.854
3.690 4.553
3.491 4.376
3.360 4.244
Oxidation with Fe3+ ion in the presence of 1,10-phenanthroline
(Method B)
4.066 3.824
3.750 3.523
3.552 3.251
3.500 3.222
4 A.A.P. Khan et al.where K0 is the pseudo ﬁrst-order rate constant of the reaction
and n is the order of the reaction. The rate may be estimated by
the variable-time method measured as DA/Dt, where A is the
absorbance and t is the time in seconds (Weisberger et al.,
1953). Taking logarithms of rates and concentration as shown
in Table 1, Eq. (4) is transformed into:
logðrateÞ ¼ logDA=Dt ¼ logK0 þ n log½FLD ð5Þ
Regression of log (rate) versus log (FLD) gave the regres-
sion equations:
logðrateÞ ¼ 0:9874þ 1:9920 log C ðr ¼ 0:9996ÞMethod APlease cite this article in press as: Khan, A.A.P. et al., Complexation and oxidation
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¼ 0:9998ÞMethod B
Hence K0 = 1.023S1 or 1.054S1, applying Methods A or
B, respectively, and the reactions can be approximated to ﬁrst
order (n  1) with respect to FLD concentration under the
optimized experimental conditions. The concentration of
FLD was determined using an excess of Fe3+ and acetate buf-
fer of pH 3.5, applying Method A.
Under second procedure excess of 1,10-phenanthroline,
Fe3+ and acetate buffer of pH 5 with respect to the initial con-
centration of FLD was taken.
However, the rate will be directly proportional to drug con-
centration in a pseudo-ﬁrst rate equation as follows:
Rate ¼ K0½drug ð6Þ
where K’ is the pseudo-order rate constant. Several experi-
ments were then carried out to obtain drug concentration from
the rate data according to Eq. (6). The rate constant, ﬁxed-
concentration and ﬁxed time methods (Yatsimirskii, (1966),
Laitinen and Harris, (1975)) were tried and the most suitable
analytical method was selected taking into account the applica-
bility, the sensitivity, the correlation coefﬁcient (r) and the
intercept.
7.2. Fixed-time method
The absorbance was measured at a preselected ﬁxed time.
Absorbance versus FLD concentration was plotted at 5 min
interval applying method A and 10 min interval under the
method B with the regression equation shown in Table 2.
The slope increases with time and the most acceptable val-
ues of the correlation coefﬁcient (r) and the intercept were
obtained for a ﬁxed time interval for measurements in Table 2.
7.3. Rate-constant method
Graphs of log (absorbance) versus time over the concentration
range of FLD 1.2 · 105–4.8 · 105 mol L1, and 1.5 · 104–
7.5 · 104 mol L1 were plotted by methods A and B respec-
tively. The pseudo-ﬁrst order rate constants corresponding to
different FLD concentrations were then calculated from the
slopes multiplied by 2.303 and listed in Table 3.of Flutamide with Fe3+ and 1,10-phenanthroline: Few analytical applications.
Table 2 Calibration equations at different ﬁxed times for
FLD in the ranges 0.5–10 lg mL1 and 0.5–1.5 lg mL1
applying methods A and B., respectively.
Time (min) Regression equation Correlation
coeﬃcient (r)
Reaction with Fe3+ (Method A)
10 A= .05655 + .04192 C 0.9912
15 A= .04687 + .04412 C 0.9832
20 A= .02116 + .05038 C 0.9997
25 A= .00095 + .0538 C 0.9981
Oxidation with Fe3+ ion in the presence of 1,10-phenanthroline
(Method B)
10 A= .04045 + .03912 C 0.9928
20 A= .01945 + .03645 C 0.9969
30 A= .0016 + .00386 C 0.9972
40 A= .00045 + .0012 C 0.9991
50 A= 2.15 · 103 + .03745 C 0.9949
60 A= 2.12 · 103 + .03932 C 0.9994
Table 3 Values of K0 calculated from slopes of log A versus t
graphs multiplied by 2.303, for different concentrations of
FLD, by applying methods A and B.
K0 (s–1) Log [FLD], (mol L–1)
Reaction with Fe3+ (Method A)
9.58 · 104 1.2 · 105
8.40 · 104 2.4 · 105
7.36 · 104 3.6 · 105
6.26 · 104 4.8 · 105
Oxidation with Fe3+ ion in the presence of 1,10-
phenanthroline(Method B)
2.44 · 104 1.5 · 105
1.66 · 104 3.0 · 105
1.57 · 104 4.5 · 105
1.25 · 104 6.0 · 105
1.10 · 104 7.5 · 105
Table 4 Values of reciprocal of time taken at ﬁxed absor-
bance (0.4 and 0.3) for different rates of various concentrations
of FLD applying methods A and B.
1/t (s1) Log [FLD], (mol L1)
Reaction with Fe3+ (Method A)
8.40 · 104 3.35 · 105
2.75 · 103 4.46 · 105
4.70 · 104 5.58 · 105
Oxidation with Fe3+ ion in the presence of 1,10-phenanthroline
(Method B)
1.21 · 103 4.5 · 103
1.63 · 103 6.02 · 104
2.06 · 103 6.70 · 104
Table 5 Evaluation of precision of the proposed kinetic
spectrophotometric method for determination of investigated
FLD by applying methods A and B.
Amount taken (lg mL1) Amount found
(lg mL1)
% Recovery ± S.D.
Reaction with Fe3+ (Method A)
10 10.05 100.50
20 20.16 99.55
30 29.91 98.50
Mean ± S.D. = 99.51
Oxidation with Fe3+ ion in the presence of 1,10-phenanthroline
(Method B)
55 54.05 100.50
150 149.98 99.75
250 250.02 99.25
Mean ± S.D. = 99.83
Table 6 Analytical parameters for the ﬁxed time method of
the kinetic spectrophotometric determination of investigated
FLD in the pure form by applying methods A and B.
Parameters Method A Method B
Optical characteristics
kmax, nm 510 510
Linearity range (lg mL1) 0.5–10 0.5–1.5
Regression equation: 0.075210 0.089392
Intercept (a)
Standard deviation of intercept 0.571274 0.471283
(Sa) 0.012716 0.002194
Slope (b) 0.00189 0.000325
Standard deviation of slope
(Sb) 0.9865 0.9928
Correlation coeﬃcient (r) 0.332 0.726
LOD (lg mL1) 0.371 0.1615
LOQ (lg mL1)
Complexation and oxidation of Flutamide 5Regression of (C) versus K0 gave the equations:
K0 ¼ 1:050 103 þ 9:92 C ðr ¼ 0:9912ÞMethod A
K0 ¼ 2:12 103 þ 2:441 ðr ¼ 0:9795ÞMethod B
The value of r is indicative of poor linearity, probably
because of inconsistency of K0.
7.4. Fixed-concentration method
Rate of reaction was recorded for different concentrations of
FLD (3.35 · 105–5.58 · 105 mol L1, and 5.36 · 105–
6.7 · 105 mol L1). A pre-selected value of the absorbance
was ﬁxed and the time was measured in seconds. The recipro-
cal of time (1/t) versus the initial concentration of FLD was
plotted in Table 4. The following equations for calibration
graphs were obtained by linear regression:
1=t ¼ 5:125 103 þ 173:92 C ðr
¼ 0:9887Þ for Methods A
1=t ¼ 2:137 103 þ 63:1 C ðr ¼ 0:9991Þ for Methods BPlease cite this article in press as: Khan, A.A.P. et al., Complexation and oxidation
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7.5.1. Accuracy and precision of the proposed methods
Accuracy and precision were checked according to USP vali-of Flutamide with Fe3+ and 1,10-phenanthroline: Few analytical applications.
Table 7 Result for determination of FLD in urine samples by the RRS method [13].
Urine Amount taken (lg mL1) Amount found (lg mL1) Mean (g) % RSD % Recovery
Sample 1 0.5 ND 0.499 0.44 99.9
Sample 2 1.0 ND 1.003 0.62 100.3
Sample 3 1.5 ND 1.504 0.89 100.2
6 A.A.P. Khan et al.dation guidelines (TUSP, 2002) at three concentration levels
within the speciﬁed range, six replicate measurements were
recorded at each concentration level presented in Table 5.
7.5.2. Limit of detection (LOD)
LOD was calculated based on standard deviation of response
and the slope of the calibration curve. The limit of detection
was expressed as:
LOD ¼ 3r=S
where r is the standard deviation of intercept. S is the slope
of the calibration curve. The results are summarized in Table 6
indicating good sensitivity of the proposed method. According
to USP validation guidelines (TUSP, 2002), the calculated
LOD values should be further validated by laboratory experi-
ments. In our work, good results were obtained where the cal-
culated drug concentration by LOD equations was actually
detected in these experiments.
7.5.3. Limit of quantitation (LOQ)
LOQ was calculated based on standard deviation of intercept
and slope of the calibration curve. In this method, the limit
of quantitation is expressed as:
LOQ ¼ 10r=S
The results indicate good sensitivity of the proposed
method in Table 5. According to USP validation guidelines
(TUSP, 2002), the calculated LOQ values should be further
validated by laboratory experiments. In our work, good results
were obtained where the calculated drug concentration by
LOQ equations was actually quantitated in these experiments.
8. TLC of FLD and its reaction products
The FLD drug, Fe3+ and its reaction products were analyzed
by thin layer chromatography. The spots test of FLD, reaction
products such as red color ternary complex of methods A and
B were with Rf values of 0.65, 0.45 and 0.60, detected
respectively.
9. Determination of FLD in urine
Authors have already carried out a detailed investigation on
the FLD determination in urine by the resonance rayleigh scat-
tering (RRS) method in their previous study (Mohd et al.,
2011) as shown in Table 7. The results portrayed that the
RRS method has good repeatability. The % RSD and %
recovery are found to lie between 0.44 and 0.89 and 99.9 and
100.3 respectively. Therefore, the method can be applied for
the determination of FLD in urine sample by future
researchers.Please cite this article in press as: Khan, A.A.P. et al., Complexation and oxidation
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The optimized methods have been applied for the determina-
tion of FLD in commercial pharmaceutical dosage forms.
The concentration of FLD determination was computed from
the regression method. The obtained results of proposed
methods were statistically compared with those of reported lit-
eratures (Saleh et al., 2003; Khan et al., 2012). The mean
recovery values were 99.51 and 99.83 respectively, which
ensures that there is no interference in the FLD of other active
compounds. The calculated and theoretical values of both the
proposed and the reported methods at 95% conﬁdence level.
This indicates good precision and accuracy for the determina-
tion of FLD in pharmaceutical dosage forms.
11. Conclusion
The determination of FLD by the proposed method is based
on its complexation and oxidation by Fe3+. Two sets of con-
ditions were established. In one set of conditions only FLD
forms complex with Fe3+ while in the other set FLD is
oxidized by Fe3+ in the presence of 1,10-phenanthroline. In
both the sets, the reactions can be monitored spectrophotomet-
rically by measuring the increase in absorbance at 510 nm. The
proposed method is sensitive enough to enable determination
of low amount of drug. These advantages encourage the appli-
cation of the proposed method in routine analysis of FLD in
industrial laboratories.
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